We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mylan Awarded Additional $13.7 Million Over Generic Paxil, Bringing Total to $120.6 Million
Mylan Awarded Additional $13.7 Million Over Generic Paxil, Bringing Total to $120.6 Million
Mylan has been awarded another $13.7 million in supplemental damages from GlaxoSmithKline in an ongoing lawsuit against the brandmaker that accuses it of violating a 2007 contract over exclusivity rights to generic antidepressant Paxil.